Concepedia

Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?

Stefan Bittmann, Anne Weissenstein, Gloria Villalon, Elena Moschüring-Alieva, Elisabeth Luchter

Journal of Clinical Medicine Research · 2020 · 32 citations · 11 references

DOIFull text

Open access

Concepts

References

11

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell · 2020 · 21.4K citations · Full text

, , +11

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Hao Xu, Liang Zhong, J. S. Deng et al. · International Journal of Oral Science · 2020 · 2.9K citations · Full text

, , +13

Cytokine release syndrome in severe COVID-19

John B. Moore, Carl H. June · Science · 2020 · 2K citations

, , +17

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan, Amy Sims, Shuntai Zhou et al. · Science Translational Medicine · 2020 · 1.2K citations · Full text

, , +17

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

Graham Simmons, Dhaval N. Gosalia, Andrew J. Rennekamp et al. · Proceedings of the National Academy of Sciences · 2005 · 1.1K citations · Full text

, , +17